Cosmo and Ferring hope to file budesonide for colitis in EU next year
This article was originally published in Scrip
Executive Summary
Cosmo Pharmaceuticalshopes to file budesonide MMX, a proprietary formulation of the older drug budesonide, for mild to moderate ulcerative colitis in the EU with development partner Ferring around March 2010, Cosmo's chief financial officer Dr Chris Tanner said.